Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Long-Term Debt Repayments (2019 - 2020)

Historic Long-Term Debt Repayments for Avidity Biosciences (RNA) over the last 2 years, with Q2 2020 value amounting to $4.0 million.

  • Avidity Biosciences' Long-Term Debt Repayments changed N/A to $4.0 million in Q2 2020 from the same period last year, while for Mar 2021 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $4.7 million for FY2020, which is 6725.0% up from last year.
  • According to the latest figures from Q2 2020, Avidity Biosciences' Long-Term Debt Repayments is $4.0 million.
  • Avidity Biosciences' 5-year Long-Term Debt Repayments high stood at $4.0 million for Q2 2020, and its period low was $700000.0 during Q3 2019.